Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men
about
Racial Differences in the Diagnosis and Treatment of Prostate CancerHuman genes involved in copy number variation: mechanisms of origin, functional effects and implications for disease.Meta-analysis reveals a lack of association between UGT2B17 deletion polymorphism and tumor susceptibility.Function of UDP-glucuronosyltransferase 2B17 (UGT2B17) is involved in endometrial cancerAssociations between polymorphisms in glucuronidation and sulfation enzymes and sex steroid concentrations in premenopausal women in the United StatesUGT genomic diversity: beyond gene duplication.Novel associations of UDP-glucuronosyltransferase 2B gene variants with prostate cancer risk in a multiethnic study.Copy number variations burden on miRNA genes reveals layers of complexities involved in the regulation of pathways and phenotypic expressionGenetic and phenotypic variation in UGT2B17, a testosterone-metabolizing enzyme, is associated with BMI in males.SNP discovery, expression and cis-regulatory variation in the UGT2B genes.Association of uridine diphosphate-glucuronosyltransferase 2B gene variants with serum glucuronide levels and prostate cancer risk.Homozygous deletion of the UGT2B17 gene is not associated with osteoporosis risk in elderly Caucasian women.A pharmacogenomics primer.The effect of copy number variation in the phase II detoxification genes UGT2B17 and UGT2B28 on colorectal cancer risk.The fine-scale and complex architecture of human copy-number variationPhase two steroid metabolism and its roles in breast and prostate cancer patientsThe interaction of genetic polymorphisms with lifestyle factors: implications for the dietary prevention of prostate cancer.UGT2B17 Polymorphism and Risk of Prostate Cancer: A Meta-Analysis.Completing the map of human genetic variation.Genetic variation in androgen disposition: implications in clinical medicine including testosterone abuse.The impact of human copy number variation on a new era of genetic testing.Genetic polymorphism in metabolism and host defense enzymes: implications for human health risk assessment.Molecular genetics of prostate cancer: emerging appreciation of genetic complexity.Human genetic variation: new challenges and opportunities for doping control.Farnesoid X receptor alpha: a molecular link between bile acids and steroid signaling?Transcriptional regulation of human UDP-glucuronosyltransferase genes.Classical and Non-Classical Roles for Pre-Receptor Control of DHT Metabolism in Prostate Cancer Progression.Genetic polymorphisms of human UDP-glucuronosyltransferase (UGT) genes and cancer risk.Pharmacogenomics and histone deacetylase inhibitors.Androgen-stimulated UDP-glucose dehydrogenase expression limits prostate androgen availability without impacting hyaluronan levels.A pharmacogenetic study of vorinostat glucuronidation.Benign, Pathogenic and Copy Number Variations of Unknown Clinical Significance in Patients with Congenital Malformations and Developmental DelayAdaptive evolution of UGT2B17 copy-number variation.UGT2B17 genetic polymorphisms dramatically affect the pharmacokinetics of MK-7246 in healthy subjects in a first-in-human study.Loss of exogenous androgen dependence by prostate tumor cells is associated with elevated glucuronidation potential.Copy number polymorphisms in new HapMap III and Singapore populations.Evaluation of UDP-glucuronosyltransferase 2B17 (UGT2B17) and dihydrofolate reductase (DHFR) genes deletion and the expression level of NGX6 mRNA in breast cancer.Classification of pathogenic or benign status of CNVs detected by microarray analysis.A physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model of the histone deacetylase (HDAC) inhibitor vorinostat for pediatric and adult patients and its application for dose specification.Impact of copy number variations burden on coding genome in humans using integrated high resolution arrays.
P2860
Q28079631-288E1D6D-2010-4395-B3E0-16245C84659DQ30479569-160CE962-3FA4-4F81-A593-D3CA29EC1706Q33573400-0F1AAB4A-60B9-4E19-B547-FE6AC196C14EQ34094975-4EB14743-045A-4382-BD6C-B86557462E8BQ34730731-B16A4E07-6512-4E88-B728-F728776229B9Q35009521-BFFCCD56-C93D-42A5-AC0E-4BF47C47643FQ35051456-6A7EC5A3-D7EE-4C27-9C4A-E73D28CFF689Q35109014-C031FE8F-46A6-409E-B15E-6623C189F58FQ35243264-03FC4687-0ED3-4F61-9839-885F385735C0Q36276855-4DF3C7E5-C35D-4E63-84F7-0C0045A27434Q36476775-0D26E59F-F02B-4BE9-ACB5-8833CF5A7A66Q36709016-17CBABC6-BA64-4755-8982-227F68DB3CABQ36896796-AB0F3844-F0B5-41AB-951A-1441A684D75EQ36940977-0D467F7C-9F58-4660-913B-538395024BA8Q37141839-B90E810A-FEC6-47BF-B81B-7AD46C7FF5DEQ37142561-EBAF04A7-8937-44F0-8940-E1AD474EC03CQ37150148-EB60F552-0DBD-4033-97C9-A5AA7FAC8E9EQ37196944-AF12D43B-5300-4BD8-89E0-501885200A8FQ37200545-BA617C6F-F0C6-4133-817F-1B7DB635DB00Q37481427-06E3ABF0-1EFC-479D-AE75-47496A55D2B8Q37682292-000B9643-48CE-4FF1-B1A8-477606DBDE73Q37775981-A7367669-EDB9-4F18-8F81-8D1A2E24FDCEQ37972706-D4AC451C-A4E0-4702-9CC7-94661940E3B8Q38017318-2215E5F4-58C6-4364-B2C2-7A954020A661Q38115716-BAB8495E-DF58-4F39-881A-32500B7A50B9Q38261875-0F98CA0C-0181-46D5-87CD-81533566CADBQ38707335-5342A0D3-9AC5-48DD-9233-549954744696Q38717288-1072C1E1-FA5C-4C18-877E-09F5560646E2Q38987332-7F468E3F-6F0C-4319-9B28-305DA3CF0561Q39879669-2D0811DC-360D-4678-BBDA-9291FC4D0A59Q40121072-E453CD46-392B-407D-A86D-8AC42D66347BQ41156123-42265366-9C57-4B0D-9B57-B3AC7AA7BF0FQ42035089-DFCE5D78-9648-45A2-94B6-D89557213F97Q42067941-2B5DB247-CC88-48E8-8978-738C09A98BA7Q42165985-78B6D9F7-C049-4477-BDAF-2982B6BDE987Q44909789-7FFD3994-5081-4000-B9A8-4B7D4DB82DBBQ45153204-2B48F331-D589-4159-AE09-A9ED1F774D69Q46427518-211E625C-3F4B-4965-A68C-2A31C74C62D9Q47843990-E3F14DD6-FDD6-497B-B664-34BDC3FD51F8Q51501425-3CF10527-FDB7-4E51-98D9-CC9FC7827B8E
P2860
Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men
description
2006 nî lūn-bûn
@nan
2006 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Deletion polymorphism of UDP-g ...... can American and Caucasian men
@ast
Deletion polymorphism of UDP-g ...... can American and Caucasian men
@en
Deletion polymorphism of UDP-g ...... can American and Caucasian men
@nl
type
label
Deletion polymorphism of UDP-g ...... can American and Caucasian men
@ast
Deletion polymorphism of UDP-g ...... can American and Caucasian men
@en
Deletion polymorphism of UDP-g ...... can American and Caucasian men
@nl
prefLabel
Deletion polymorphism of UDP-g ...... can American and Caucasian men
@ast
Deletion polymorphism of UDP-g ...... can American and Caucasian men
@en
Deletion polymorphism of UDP-g ...... can American and Caucasian men
@nl
P2093
P1476
Deletion polymorphism of UDP-g ...... can American and Caucasian men
@en
P2093
Babu Zachariah
Fred F Kadlubar
Jean-Paul Tanner
Ji-Hyun Lee
Julio Pow-Sang
Luke Ratnashinge
Nicholas Lang
Nicole Dossett
P304
P356
10.1158/1055-9965.EPI-06-0141
P407
P577
2006-08-01T00:00:00Z